Glenmede Trust CO Na Athersys, Inc Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	BUY	$1.91 - $3.08 $7,640 - $12,320	4,000 Added 47.06%	12,500 $24,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.65 $6,050 - $8,250	-5,000 Reduced 37.04%	8,500 $11,000
Q4 2018 Feb 14, 2019	SELL	$1.41 - $2.16 $12,690 - $19,440	-9,000 Reduced 40.0%	13,500 $19,000
Q3 2017 Nov 14, 2017	BUY	$1.5 - $2.55 $33,750 - $57,374	22,500	22,500 $0

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.